Kuki, Japan

Asato Kojima

This inventor holds 1 USPTO granted patent. Top assignees: Director-General of National Institute of Health, Nippon Zeon Company, Ltd., Tokyo Metropolitan Institute for Neuroscience. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Asato Kojima. Retrieved from https://idiyas.com/inventor/asato-kojima-n89509dl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Asato Kojima: Innovator in Vaccinia Virus Research

Introduction

Asato Kojima is a notable inventor based in Kuki, Japan. He has made significant contributions to the field of virology, particularly in the development of vaccines. His innovative work has led to advancements that could potentially improve public health.

Latest Patents

Kojima holds a patent for a recombinant vaccinia virus expressing the E-protein of the Japanese encephalitis virus. This recombinant vaccinia virus has cDNA coding for the E-protein inserted into a genome region that is non-essential for the growth of the vaccinia virus. This innovation is particularly valuable as it serves as a live vaccine, offering a new approach to combating Japanese encephalitis.

Career Highlights

Throughout his career, Kojima has worked with prominent organizations, including Nippon Zeon Company, Ltd. He has also served as the Director-General of the National Institute of Health, where he played a crucial role in advancing health research and innovation.

Collaborations

Kojima has collaborated with esteemed colleagues such as Kotaro Yasui and Atsushi Yasuda. These partnerships have contributed to the success of his research and the development of his patented technologies.

Conclusion

Asato Kojima's work in the field of virology, particularly with his recombinant vaccinia virus patent, showcases his dedication to advancing medical science. His contributions are significant in the ongoing efforts to develop effective vaccines and improve public health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…